Eltrombopag Tablet Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets & Oral Powder for Oral Suspension
Available Strengths: Tablet: 12.5 mg, 25 mg, 50 mg, 75 mg; Suspension:25 mg per packet
Reference Brands: Promacta,Revolade
Category: Anemia
Eltrombopag is an oral thrombopoietin receptor agonist used to treat chronic ITP, severe aplastic anemia, and hepatitis C-related thrombocytopenia. Marketed as Promacta and Revolade, it boosts platelet production and reduces transfusion needs. Ideal for pharma B2B sourcing.
Product Description:
Eltrombopag is a thrombopoietin receptor agonist used to treat chronic immune thrombocytopenia (ITP), severe aplastic anemia (SAA), and hepatitis C-associated thrombocytopenia. Marketed globally as Promacta (US) and Revolade (EU/Worldwide), it stimulates platelet production and reduces bleeding risk. Available in GMP-certified oral tablets and pediatric suspension, Eltrombopag is a high-demand product in hematology. Ideal for pharmaceutical wholesalers, importers, and B2B buyers seeking reliable sourcing of specialty medicines. We offer bulk supply, export support, and regulatory documentation. Partner with us for competitive pricing and global delivery of Eltrombopag. Contact us today to secure your supply of Eltrombopag for pharma B2B needs.
Eltrombopag Tablet — third party manufacturing & bulk supply
Eltrombopag Tablet is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Eltrombopag Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Eltrombopag Tablet →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Eltrombopag is used to increase platelet counts in patients with chronic immune thrombocytopenia (ITP), thrombocytopenia caused by chronic hepatitis C, and severe aplastic anaemia. It helps stimulate platelet production in the bone marrow.
It is made from the active molecule eltrombopag olamine, a small-molecule thrombopoietin receptor agonist that binds to the TPO receptor and promotes platelet growth.
Its main trade names are Promacta and Revolade in different regions.
The original brand is produced by Novartis, and several other licensed manufacturers produce generic versions globally.
The generic name is Eltrombopag, commonly in the form of eltrombopag olamine.
Brand names include Promacta and Revolade.
It is manufactured in multiple countries through Novartis facilities and approved global generic manufacturers.
Related Products
Mitapivat Sulfate
Strength:
5 mg, 20 mg, 50 mg
Form: Tablets
Reference Brands: Pyrukynd (USA)
View Details
Eltrombopag Cholin 50 Mg Tablet
Strength:
12.5 mg, 25 mg, 50 mg, and 75 mg
Form: Tablets / Oral suspension
Reference Brands: Promacta (USA), Revolade (EU)
View Details
Epoetin Alfa
Strength:
1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Form: injection (prefilled syringe)
Reference Brands: EPOGEN (USA), PROCRIT (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
